These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2008271)

  • 1. Excimer laser ablative treatment of microbial keratitis.
    Gottsch JD; Gilbert ML; Goodman DF; Sulewski ME; Dick JD; Stark WJ
    Ophthalmology; 1991 Feb; 98(2):146-9. PubMed ID: 2008271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extensive lamellar keratectomy for treatment of nontuberculous mycobacterial keratitis.
    Hu FR
    Am J Ophthalmol; 1995 Jul; 120(1):47-54. PubMed ID: 7611329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacterium chelonae keratitis following laser in situ keratomileusis.
    Reviglio V; Rodriguez ML; Picotti GS; Paradello M; Luna JD; Juárez CP
    J Refract Surg; 1998; 14(3):357-60. PubMed ID: 9641428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of topical gentamicin treatment after 193-nm photorefractive keratectomy in an experimental Pseudomonas keratitis model.
    Frucht-Pery J; Golan G; Hemo I; Zauberman H; Shapiro M
    Graefes Arch Clin Exp Ophthalmol; 1995 Aug; 233(8):532-4. PubMed ID: 8537030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic study of satellite lesions in nontuberculous mycobacterial keratitis.
    Hu FR; Huang WJ; Huang SF
    Jpn J Ophthalmol; 1998; 42(2):115-8. PubMed ID: 9587843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium fortuitum keratitis. Clinicopathologic correlates and corticosteroid effects in an animal model.
    Paschal JF; Holland GN; Sison RF; Berlin OG; Bruckner DA; Dugel PU; Foos RY
    Cornea; 1992 Nov; 11(6):493-9. PubMed ID: 1468210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of topical ciprofloxacin for treating Mycobacterium fortuitum and Mycobacterium chelonae keratitis in an animal model.
    Lin R; Holland GN; Helm CJ; Elias SJ; Berlin OG; Bruckner DA
    Am J Ophthalmol; 1994 May; 117(5):657-62. PubMed ID: 8172274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of corneal collagen cross-linking (PACK-CXL) and voriconazole treatments in experimental fungal keratitis.
    Özdemir HB; Kalkancı A; Bilgihan K; Göçün PU; Öğüt B; Karakurt F; Erdoğan M
    Acta Ophthalmol; 2019 Feb; 97(1):e91-e96. PubMed ID: 29862655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of agent and host factors in progression of mycotic keratitis: A histologic and microbiologic study of 167 corneal buttons.
    Vemuganti GK; Garg P; Gopinathan U; Naduvilath TJ; John RK; Buddi R; Rao GN
    Ophthalmology; 2002 Aug; 109(8):1538-46. PubMed ID: 12153808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical ciprofloxacin for treating nontuberculous mycobacterial keratitis.
    Hu FR; Luh KT
    Ophthalmology; 1998 Feb; 105(2):269-72. PubMed ID: 9479286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppression affects the severity of experimental Fusarium solani keratitis.
    Wu TG; Keasler VV; Mitchell BM; Wilhelmus KR
    J Infect Dis; 2004 Jul; 190(1):192-8. PubMed ID: 15195260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beauveria bassiana keratitis cured by deep lamellar dissection.
    Low CD; Badenoch PR; Coster DJ
    Cornea; 1997 Nov; 16(6):698-9. PubMed ID: 9395884
    [No Abstract]   [Full Text] [Related]  

  • 13. Results of therapeutic penetrating keratoplasty for bacterial and fungal keratitis.
    Koçluk Y; Sukgen EA
    Int Ophthalmol; 2017 Oct; 37(5):1085-1093. PubMed ID: 27723008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium chelonae keratitis after excimer laser photorefractive keratectomy.
    Brancato R; Carones F; Venturi E; Cavallero A; Gesu G
    Arch Ophthalmol; 1997 Oct; 115(10):1316-8. PubMed ID: 9338681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of activated macrophages in experimental Fusarium solani keratitis.
    Hu J; Hu Y; Chen S; Dong C; Zhang J; Li Y; Yang J; Han X; Zhu X; Xu G
    Exp Eye Res; 2014 Dec; 129():57-65. PubMed ID: 25447809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interface keratitis due to Mycobacterium fortuitum following laser in situ keratomileusis.
    Fogla R; Rao SK; Padmanabhan P
    Indian J Ophthalmol; 2003 Sep; 51(3):263-5. PubMed ID: 14601856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of topical antibiotics for treating Mycobacterium fortuitum keratitis in an animal model.
    Helm CJ; Holland GN; Lin R; Berlin OG; Bruckner DA
    Am J Ophthalmol; 1993 Dec; 116(6):700-7. PubMed ID: 8250072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic lamellar keratectomy in the management of nontuberculous Mycobacterium keratitis refractory to medical treatments.
    Tseng SH; Hsiao WC
    Cornea; 1995 Mar; 14(2):161-6. PubMed ID: 7743799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cluster of Mycobacterium chelonae keratitis cases following laser in-situ keratomileusis.
    Chandra NS; Torres MF; Winthrop KL; Bruckner DA; Heidemann DG; Calvet HM; Yakrus M; Mondino BJ; Holland GN
    Am J Ophthalmol; 2001 Dec; 132(6):819-30. PubMed ID: 11730644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral Mycobacterium chelonae keratitis after laser in situ keratomileusis.
    Sun YC; Wang IJ; Hu FR
    Jpn J Ophthalmol; 2006; 50(3):285-7. PubMed ID: 16767388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.